Niagen Bioscience (NAGE) Capital Expenditures Growth (1y) (2012 - 2020)
Niagen Bioscience (NAGE) Capital Expenditures Growth (1y) (2012 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | Niagen Bioscience | 258.53 Mn | 191.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 33.33% |
| Mar 31, 2020 | -93.72% |
| Dec 31, 2019 | 2,700.00% |
| Sep 30, 2019 | 318.92% |
| Jun 30, 2019 | -93.80% |
| Mar 31, 2019 | 48.45% |
| Dec 31, 2018 | -96.61% |
| Sep 30, 2018 | -93.59% |
| Jun 30, 2018 | 736.84% |
| Mar 31, 2018 | -0.62% |
| Dec 30, 2017 | -47.69% |
| Sep 30, 2017 | -18.71% |
| Jul 1, 2017 | -38.02% |
| Apr 1, 2017 | 874.20% |
| Dec 31, 2016 | 19.53% |
| Mar 30, 2013 | 57.57% |
| Dec 29, 2012 | -55.58% |
| Sep 29, 2012 | -93.38% |
| Jun 30, 2012 | -83.06% |
| Mar 31, 2012 | -91.97% |